Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-02-26 @ 2:16 AM
Study NCT ID:
NCT00667251
Status:
COMPLETED
Last Update Posted:
2025-03-21
First Post:
2008-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10-07
Start Date Type:
ACTUAL
Primary Completion Date:
2012-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-27
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-25
First Submit QC Date:
None
Study First Post Date:
2008-04-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-09-24
Results First Submit QC Date:
None
Results First Post Date:
2014-06-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-21
Last Update Post Date Type:
ACTUAL